FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes the novel derivatives of indole of the general formula (I) and their tautomers where R1 is hydrogen, halogen atoms, lower alkyl, hydroxyl, nitro-group, trifluoromethyl, groups OCOR and OR where R means lower alkyl being residue R1 can replace a single group of ring with aza-atom; R2 means groups: (CH2)n-COOH, (CH2)nCONH2, (CH2)n-COOR, (CH2)n-CONHR, (CH2)n-CONRR, (CH2)nCONHCH2Ph, CONHR, CONRR, CONHPh, COPhCOOH, COPhCOOR, (CH2)n-CONHPh or (CH2)n-CONHPhR where R has the above indicated value; Ph means phenyl; n = 1-4; groups COY and SO2Y where Y means unsubstituted phenyl or phenyl substituted with lower alkyl, carboxyl or group OCOR where R has the above indicated value; R3 is hydrogen atom, benzyl; R4 is groups: SH, S0X,S0Q1 Se0Q′ where o = 1, 2 or 3; X is hydrogen atom, lower alkyl, benzyl; Q is 2-thio-indolyl of the general formula (I); Q′ is 2-selenoindolyl of the general formula (I) under condition that if R4 means Se0Q′, then R2 means groups COOR5 where R5 means hydrogen atom or lower alkyl, -CONHR6 where R6 means lower alkyl or (CH2)2-lower dialkyl or group where R2 means amino-group and Ph is phenyl but the following compounds are excluded: 2-(2-thioxo- -3-indolinyl)-acetic acid, 2-(1-methyl-2-thioxo-3-indolinyl)-acetic acid, methyl-2-(2-thioxo-3-indolinyl)acetate, ethyl- -2-(1-methyl-2-thioxo-3-indolinyl)acetate, bis-[methyl- -indolinyl-3-acetate-(2)] disulfide, bis-[indolyl-3-acetic acid-(2)] disulfide, bis-[methylindolyl-3-acetate-(2)] trisulfide, bis-[1-methylindolyl-3-acetic acid-(2)] disulfide, 2,3-dihydro-2-thioxo-1H-indole-3-acetic acid methyl ester and 2-(methylthio)-1H-indole-3-acetic acid methyl ester, mixtures of their isomers or separate isomers and pharmaceutically acceptable salts. Compounds of the formula (I) show valuable pharmacological properties, in part, they can be used as inhibitors of protein tyrosine kinase and an antitumor agent. Invention describes also pharmaceutical composition based on compounds of the formula (I), method of inhibition of protein tyrosine kinase depending disease or control of aberrant growth of mammalian or human cells. EFFECT: valuable medicinal properties of compounds. 4 cl, 3 tbl, 9 ex
Authors
Dates
2000-08-27—Published
1993-08-02—Filed